462 related articles for article (PubMed ID: 24639417)
1. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
[TBL] [Abstract][Full Text] [Related]
2. Relationship between body mass index and alanine aminotransferase concentration in non-diabetic Korean adults.
Kim J; Jo I
Eur J Clin Nutr; 2010 Feb; 64(2):169-75. PubMed ID: 19904291
[TBL] [Abstract][Full Text] [Related]
3. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
[TBL] [Abstract][Full Text] [Related]
4. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
Sogabe M; Okahisa T; Nakagawa T; Fukuno H; Nakasono M; Tomonari T; Tanaka T; Tanaka H; Taniguchi T; Muguruma N; Takayama T
BMC Gastroenterol; 2016 Feb; 16():17. PubMed ID: 26892109
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
[TBL] [Abstract][Full Text] [Related]
6. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
7. Elevated alanine aminotransferase is associated with metabolic syndrome but not consistently associated with impaired fasting glucose or type 2 diabetes mellitus.
Yueh CY; Chen JH; Lee LW; Lu CW; Parekh B; Chi CC
Diabetes Res Clin Pract; 2011 Oct; 94(1):64-70. PubMed ID: 21715038
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle and clinical factors associated with elevated C-reactive protein among newly diagnosed Type 2 diabetes mellitus patients: a cross-sectional study from the nationwide DD2 cohort.
Svensson E; Mor A; Rungby J; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
BMC Endocr Disord; 2014 Aug; 14():74. PubMed ID: 25163828
[TBL] [Abstract][Full Text] [Related]
10. Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes.
Afarideh M; Aryan Z; Ghajar A; Noshad S; Nakhjavani M; Baber U; Mechanick JI; Esteghamati A
Atherosclerosis; 2016 Nov; 254():42-51. PubMed ID: 27684605
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of alanine aminotransferase in Chilean population: analysis of results of the national health survey 2009-2010].
Tejos R; Padilla O; Pizarro M; Solís N; Arab JP; Margozzini P; Miquel JF; Riquelme A; Arrese M
Rev Med Chil; 2013 Jul; 141(7):909-16. PubMed ID: 24356740
[TBL] [Abstract][Full Text] [Related]
12. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
[TBL] [Abstract][Full Text] [Related]
13. Increased liver markers are associated with higher risk of type 2 diabetes.
Ko SH; Baeg MK; Han KD; Ko SH; Ahn YB
World J Gastroenterol; 2015 Jun; 21(24):7478-87. PubMed ID: 26139993
[TBL] [Abstract][Full Text] [Related]
14. Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.
Wong CA; Araneta MR; Barrett-Connor E; Alcaraz J; Castañeda D; Macera C
Diabetes Res Clin Pract; 2008 Jan; 79(1):133-40. PubMed ID: 17764776
[TBL] [Abstract][Full Text] [Related]
15. Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B
Eur Rev Med Pharmacol Sci; 2013; 17(15):2059-64. PubMed ID: 23884827
[TBL] [Abstract][Full Text] [Related]
16. Association of serum gamma-glutamyltransferase and alanine aminotransferase activities with risk of type 2 diabetes mellitus independent of fatty liver.
Kim CH; Park JY; Lee KU; Kim JH; Kim HK
Diabetes Metab Res Rev; 2009 Jan; 25(1):64-9. PubMed ID: 19065605
[TBL] [Abstract][Full Text] [Related]
17. The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
Sogabe M; Okahisa T; Nakasono M; Fukuno H; Miyamoto Y; Okada Y; Okazaki J; Miyoshi J; Tomonari T; Taniguchi T; Goji T; Kitamura S; Miyamoto H; Muguruma N; Takayama T
PLoS One; 2017; 12(6):e0177925. PubMed ID: 28574988
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
20. Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.
Frediani JK; Naioti EA; Vos MB; Figueroa J; Marsit CJ; Welsh JA
Environ Health; 2018 Jan; 17(1):6. PubMed ID: 29334960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]